All Stories

  1. Targeting SOX2 in anticancer therapy

    Article • Expert Opinion on Therapeutic Targets, October 2018, Taylor & Francis

    Professor Jochen Utikal

  2. Liquid Profiling of Circulating Tumor DNA in Plasma of Melanoma Patients for Companion Diagnostics and Monitoring of BRAF Inhibitor Therapy

    Article • Clinical Chemistry, February 2018, AACC

    Professor Jochen Utikal, Verena Haselmann

  3. Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

    Article • Stem Cells International, January 2018, Hindawi Publishing Corporation

    Professor Jochen Utikal

  4. Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)

    Article • OncoImmunology, May 2017, Taylor & Francis

    Professor Jochen Utikal

  5. Leukocyte Count Restoration Under Dabrafenib Treatment in a Melanoma Patient With Vemurafenib-Induced Leukopenia

    Article • Medicine, December 2014, Wolters Kluwer Health

    Professor Jochen Utikal

  6. Ultraviolet exposure and risk of melanoma and basal cell carcinoma in Ulm and Dresden, Germany

    Article • Journal of the European Academy of Dermatology and Venereology, March 2014, Wiley

    Professor Jochen Utikal